PodcastIntel
Sign in Get Started Free
All-In with Chamath, Jason, Sacks & Friedberg
All-In with Chamath, Jason, Sacks & Friedberg

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 · 30:40
Listen to Episode
✨ AI Summary
  • Eli Lilly CEO Dave Ricks discusses GLP-1 breakthroughs and pricing.
  • He shares his personal health regimen and insights on addiction.
  • Ricks touches on counterfeit products and biotech VC trends.

More from All-In with Chamath, Jason, Sacks & Friedberg

All-In with Chamath, Jason, Sacks & Friedberg
Is Claude Conscious? Pope Rejects, Model Welfare Movement, OpenAI's Math Backlash, France Riots
Oct 10, 2026 · 01:33:15
All-In with Chamath, Jason, Sacks & Friedberg
Trump's Super Intelligence Summit, AI Safety Accord, GDP Beats, Midterm Predictions
Oct 2, 2026 · 01:22:29
All-In with Chamath, Jason, Sacks & Friedberg
Jake Paul & The Chainsmokers: Turning Fame into Funds, Jake Enters Politics? & Venture Bubble Signs
Sep 30, 2026 · 52:49
All-In with Chamath, Jason, Sacks & Friedberg
Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential
Sep 28, 2026 · 51:16
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to All-In with Chamath, Jason, Sacks & Friedberg and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →